Remus Pharmaceuticals IPO GMP, Grey Market Premium Today

Vijay Prajapati
May 29, 2023

Vijay Prajapati

Check out Remus Pharmaceuticals IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Remus Pharmaceuticals IPO GMP is on a positive and going up as the subscription numbers was good. Stay tuned for the latest IPO GMP numbers of Remus Pharmaceuticals IPO.

Remus Pharmaceuticals IPO is to open on May 17. The company is to raise ₹47.69 crores via IPO. Remus Pharmaceuticals Limited is marketing, distributes, and exporting finished formulations of pharmaceutical drugs. The company is backed by expert scientists. The company deals in API and provides technical consultancy services. The company reported revenue of ₹25.44 crores in 2022 against revenues of ₹19.22 crores in 2021. The IPO price band is fixed at ₹1150 to ₹1229 Per Equity Share. The Remus Pharmaceuticals IPO to list on NSE.

What is Remus Pharmaceuticals IPO GMP Today?

The Remus Pharmaceuticals IPO GMP aka Grey Market Premium is ₹600.

What is Remus Pharmaceuticals IPO Kostak Rates Today?

The Remus Pharmaceuticals IPO Kostak Rate is ₹-.

What is Remus Pharmaceuticals IPO Subject to Sauda Price Today?

The Remus Pharmaceuticals IPO subject to sauda rates is ₹55000.

Remus Pharmaceuticals IPO Expected Returns?

The Remus Pharmaceuticals expected return is 49%.

Remus Pharmaceuticals IPO GMP Live Rates day by day with Kotak rates.

Date	GMP	Kostak	Subject to
Today	₹600	₹-	₹55000
25 May	₹400	₹-	₹35000
24 May	₹400	₹-	₹35000
23 May	₹350	₹-	₹35000
22 May	₹80	₹-	₹10000
19 May	₹50	₹-	₹6000
18 May	₹70	₹-	₹6000
17 May	₹70	₹-	₹6000
16 May	₹100	₹-	₹7000
15 May	₹100	₹-	₹7000
13 May	₹150	₹-	₹7000
12 May	₹125	₹600	₹6000
11 May	₹125	₹600	₹6000
10 May	₹-	₹-	₹-
9 May	₹-	₹-	₹-

Remus Pharmaceuticals IPO GMP aka Grey Market Premium FAQs:

What is Remus Pharmaceuticals IPO GMP Today?

Remus Pharmaceuticals IPO GMP is ₹600 as of today.

What is Remus Pharmaceuticals IPO Kostak Rate Today?

Remus Pharmaceuticals IPO Kostak Rate is ₹- as of today.

What is Remus Pharmaceuticals IPO Subject to Sauda Today?

Remus Pharmaceuticals IPO Subject to Sauda is ₹55000 as of today.

What is Remus Pharmaceuticals IPO Expected Returns?

Remus Pharmaceuticals IPO Expected Returns is 49%.

Disclaimer:

IPO Grey Market Premium (Remus Pharmaceuticals IPO GMP) mention is valid for the specific date as mentioned in the header.
We are not buying and selling IPO forms on IPO Grey Market.
Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.

Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.